Area of research
Molecular Biology · Toxicology
Research interest
Research interests include Chemistry, Pharmacology, Medicine, In silico, Oxidative stress, and Biochemistry.
ROS-Scavenging Selenofluoxetine Derivatives Inhibit <i>In Vivo</i> Serotonin Reuptake
Therapeutic Potential of Phosphodiesterase Inhibitors against Neurodegeneration: The Perspective of the Medicinal Chemist
Antioxidant Potential of Psychotropic Drugs: From Clinical Evidence to In Vitro and In Vivo Assessment and toward a New Challenge for in Silico Molecular Design
Plant natural products with anti-thyroid cancer activity
A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
A novel class of selective CK2 inhibitors targeting its open hinge conformation
Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression
Semi-synthetic isoflavones as BACE-1 inhibitors against Alzheimer’s disease
Major Depressive Disorder and Oxidative Stress: In Silico Investigation of Fluoxetine Activity against ROS
Effects of point mutations in the binding pocket of the mouse major urinary protein MUP20 on ligand affinity and specificity
Natural phosphodiesterase 5 (PDE5) inhibitors: a computational approach
Biological effects and potential mechanisms of action of Pistacia lentiscus Chios mastic extract in Caco-2 cell model
Synthesis and biological evaluation of heteroalicyclic cyanoguanidines at histamine receptors
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL
The Medicinal Chemistry of Natural and Semisynthetic Compounds against Parkinson’s and Huntington’s Diseases
An Overview of New Possible Treatments of Alzheimer's Disease, Based on Natural Products and Semi-Synthetic Compounds
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
Preliminary studies of berberine and its semi-synthetic derivatives as a promising class of multi-target anti-parkinson agents
Mechanistic Insight into the Oxidation of Organic Phenylselenides by H<sub>2</sub>O<sub>2</sub>
New Therapeutic Applications of Phosphodiesterase 5 Inhibitors (PDE5-Is)
Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human Melanoma
Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity
New naphthoquinone derivatives against glioma cells
Identification and Characterization of New DNA G-Quadruplex Binders Selected by a Combination of Ligand and Structure-Based Virtual Screening Approaches
Iodine status in schoolchildren living in northeast italy:the importance of iodized-salt use and milk consumption
Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases
Ellagic Acid and Polyhydroxylated Urolithins Are Potent Catalytic Inhibitors of Human Topoisomerase II: An in Vitro Study